| Name | NU5455 |
|---|---|
| Synonyms | 4-Morpholineacetamide, N-methyl-N-[6-[2-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-4-oxo-4H-1-benzopyran-8-yl]-2-dibenzothienyl] |
| Description | NU5455 is a potent, selective, and orally active inhibitor of DNA-PKcs. NU5455 administration increases both the efficacy and the toxicity of a parenterally administered topoisomerase inhibitor. NU5455 enhances the activity of Doxorubicin released locally in liver tumor xenografts without inducing any adverse effect[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C34H33N3O5S |
|---|---|
| Molecular Weight | 595.71 |